eQuantX help in building an-evidence based value frameworks and pricing strategies to optimize your product’s market access plans around the world. Our team of market access experts support you in accelerating your product approvals, assessing market risk, establishing appropriate pricing, and increasing speed to market for new and innovative products
How we do it
1. Market Access Environment Assessment
This usually performed at the starting of the phase-II studies and focused on the following information to be gathered
Country Healthcare System:- Understanding country-specific healthcare systems and their requirements- Epidemiology Study :- Understanding of disease management and unmet needs
- Clinical Evidence Analysis- Understanding of which clinical evidence seems to have mostly impacted in the past
- Reimbursement Scenario- Country reimbursement status of current treatments and existing restrictions
2. Designing Preliminary Market Access Plan
The preliminary market access plan is developed based on initial reaction of payers and physicians on the drafted Target Product Profile (TPP). This step plans specific studies and analysis as follows
- Disease Background
- Payer Insight Generation
- Testing and Adapting Target Product Profile
- Pricing Study
- Payer Engagement Capability Building
- Reimbursement Opportunities and Strategy
- Clinical/economic Impact Analysis/ Budget Impact Analysis
3. Gap Analysis
After discussion on the given TPP, gap analysis is performed to check the evidence require for desired market access positioning and to achieve ultimate commercial goals. This step has clearly defined objectives and stages to create value through significant development of clinical data and HEOR data/ RWE insights generation.
The output from this Gap Analysis is used into phase III clinical and Real-World Evidence research programs.
4.Designing Final Market Access Plan
Through continuous RWE data development plan and analysis, and once the clinical trial results are available from phase III studies, the Market Access plan can be finalized along with the estimated timelines. A subsequent repositioning/ re-pricing strategies could also be proposed and planned accordingly
- Disease Background
- Developing Negotiation Pathways etc.
- Repositioning Strategy
- Re-Pricing Strategy
ll FEATURED ACTIVITIES ll
ll FEATURED PRODUCTS ll
What Differentiates Us
Impact by numbers
0
+
Completed full market
access support planning for the developing
pipeline assets
access support planning for the developing
pipeline assets
0
+
Global markets experience in conducting market access studies across Asian, EU and America region
0
+
MA studies accomplished by using eQuantX’ unique PayerPro360 tool developed to get quick and real-time payer insights
0
+
Payer engagement
research completed in
US and EU markets
research completed in
US and EU markets
0
+
Patient access programs designed to enhance patient affordability, adherence, and overall access to the innovative product
0
+
Global network of national,regional and local payers to getreal-time market access insights
0
+
TPP discussed withKOLs and Payers on variousmarket access projects
0
+
Customised pricinganalytics tools andplat form built for global clients
0
+
In-depth interviews were conducted with payers, former agency officials, and subject matter experts across various MA projects
Case Studies
